Rubicon Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Rubicon Advisors's MRNA Position: Q3 2026 in Review
Rubicon Advisors opened a new position in Moderna (MRNA) in Q3 2026: 2,035 shares worth $392K. The stake represents 0.27% of the portfolio and ranks #67 among its holdings.
1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Rubicon Advisors held 2,035 shares of Moderna worth $392K as of Q3 2026.
- Moderna was a new Rubicon Advisors position in Q3 2026.
- Moderna made up 0.27% of Rubicon Advisors's portfolio in Q3 2026, its #67 holding.
- 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Rubicon Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.